UMass Memorial Wins Approval for $54 Million Cancer Center

A state board has approved a significant expansion in cancer care, granting UMass Memorial Health the go-ahead to construct a new cancer treatment facility in Marlborough, Massachusetts. The project, valued at $54 million, aims to provide advanced proton therapy, an innovative alternative to traditional radiation treatment. This development is poised to enhance access to specialized cancer care for local patients, who currently travel long distances for such services.

The Massachusetts Public Health Council’s endorsement marks a pivotal step in addressing the rising demand for cancer treatment in the region. Proton therapy utilizes a beam of charged protons to target tumors more precisely than conventional X-ray radiation, which can inadvertently damage surrounding healthy tissues. UMass Memorial officials emphasize that this facility will significantly improve patient outcomes and quality of life, particularly as cancer cases continue to increase in Central Massachusetts and beyond.

Shelly Hazlett, a spokesperson for UMass Memorial, stated in an email, “As the incidence of cancer cases rises… we’re committed to remaining a leader in clinical innovation. This project is a critical component of improving the health and quality of life of the patients that entrust us with their care.”

Meeting Local Needs with Advanced Technology

Currently, there are only two proton therapy units available in New England, both located at the Massachusetts General Hospital in Boston. These units collectively treat approximately 640 patients annually, according to state public health officials. The limited availability often forces patients to seek treatment in New York or other distant locations.

UMass Memorial’s new facility is anticipated to alleviate this burden, making proton therapy more accessible. In addition to UMass Memorial’s plans, Dana-Farber Cancer Institute is also planning to establish a proton therapy center in Boston’s Longwood neighborhood, a project estimated at $50 million that is still under review.

Dr. Allison O’Neill, vice president for clinical performance management at Dana-Farber, recently noted the existing “unmet need” for advanced cancer treatment options in the area.

Proton Therapy: Benefits and Considerations

Proponents of proton therapy highlight its effectiveness, particularly for pediatric patients, as it minimizes damage to healthy tissues while delivering targeted treatment. As research evolves, the therapy’s higher costs have drawn scrutiny, with some critics questioning whether the benefits justify the investment. However, UMass Memorial leaders assert that advancements in technology have contributed to decreasing costs, making the therapy a viable option for more patients.

They also emphasize that proton therapy can reduce the need for extensive follow-up care, further enhancing patients’ quality of life. As UMass Memorial moves forward with this project, it aims not only to expand treatment options but also to reaffirm its commitment to leading the way in cancer care innovation in Massachusetts.